Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases.

Karagianni K, Bibi A, Madé A, Acharya S, Parkkonen M, Barbalata T, Srivastava PK, de Gonzalo-Calvo D, Emanueli C, Martelli F, Devaux Y, Dafou D, Nossent AY, EU-CardioRNA COST Action CA17129

Open source

DOI
10.1016/j.omtn.2023.102085
Published
2024 Mar 12
Container
Molecular therapy. Nucleic acids
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omtn.2023.102085,
  title = {Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases.},
  author = {Karagianni K and Bibi A and Madé A and Acharya S and Parkkonen M and Barbalata T and Srivastava PK and de Gonzalo-Calvo D and Emanueli C and Martelli F and Devaux Y and Dafou D and Nossent AY and EU-CardioRNA COST Action CA17129},
  year = {2024},
  journal = {Molecular therapy. Nucleic acids},
  doi = {10.1016/j.omtn.2023.102085},
  url = {https://doi.org/10.1016/j.omtn.2023.102085}
}

RIS

TY  - JOUR
TI  - Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases.
AU  - Karagianni K
AU  - Bibi A
AU  - Madé A
AU  - Acharya S
AU  - Parkkonen M
AU  - Barbalata T
AU  - Srivastava PK
AU  - de Gonzalo-Calvo D
AU  - Emanueli C
AU  - Martelli F
AU  - Devaux Y
AU  - Dafou D
AU  - Nossent AY
AU  - EU-CardioRNA COST Action CA17129
PY  - 2024
JO  - Molecular therapy. Nucleic acids
DO  - 10.1016/j.omtn.2023.102085
UR  - https://doi.org/10.1016/j.omtn.2023.102085
ER  - 

APA

K, K., A, B., A, M., S, A., M, P., T, B., PK, S., D, D. G., C, E., F, M., Y, D., D, D., AY, N., & CA17129, E. C. A. (2024). Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2023.102085

Source records